FdaApplication
ANDA 220309
Identifiers
- fda_app_no: ANDA220309
Properties
| Property | Value |
|---|---|
| applicant_name | RENATA PLC |
| application_type | ANDA |
| approval_date | 2026-06-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CABERGOLINE | CABERGOLINE | 0.5MG | TABLET;ORAL |
1 product